Hidekazu aoyama, et.Al., "midterm results after implantation of the 3rd generation des in our hospital and a study of in-stent covering by using oct." 2018-08-02, 9:45-10:45, 9, 4f 402.Device is combination product date of death and date of event: unknown, estimated as first day of publication month.(b)(6).
|
It was reported via journal article that stent thrombosis occurred.This study enrolled 209 drug eluting stent patients (91 fast-release zotarolimus-eluting stents (zess), 40 slow-release zess, 37 durable polymer cobalt-chromium (cocr) everolimus-eluting stents (eess), 4 durable polymer platinum-chromium (ptcr) eess, 25 bioresorbable polymer ptcr eess (synergy), 12 bioresorbable polymer cocr sirolimus-eluting stents) from 135 patients (male 83%, age 69 plus or minus 10 years).They evaluated predictors for intra-stent thrombus by coronary angioscopy 4 months plus or minus 1 month after the implantation.Intra-stent thrombus was observed in 65 stents (31%).Multivariate analysis demonstrated that dyslipidemia, hemodialysis and fast-release zes implantation were associated with presence of intra stent thrombus.This result may indicate the need of dual antiplatelet therapy (dapt) continuation beyond 4 months for patients with hemodialysis and dyslipidemia, whereas we may safely switch dapt to single antiplatelet therapy in early phase for patients treated with fast-release zes.
|